Flow cytometry analysis revealed that before treatment, the proportions of both CD4+ GZMK+ and CD8+ GZMK+ T cells were greater in the PBMCs of AIS patients than in those of non-stroke controls (Figs. 2J, K and S10A). This evidence concerns the gene CD4 and Stroke.